SMITH PATRICK F

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
8
Insider Sells Sum
$1.28M

Insider Activity of SMITH PATRICK F

According to the SEC Form 4 filings, SMITH PATRICK F, being in a position of

  1. PRESIDENT, DRUG DEV SOLUTIONS at Certara, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 24836 shares for $392,823,
    over all time since 2022-04-01, has bought 0 shares, and sold 69679 shares for $1.28M.

The largest sale of all time was on 2023-06-05 and amounted to 19104 shares of Certara, Inc. for $411,691.

Biography of SMITH PATRICK F

No biography is available at this moment.

2024-10-07SaleCertara, Inc.
CERT
PRESIDENT, DRUG DEV SOLUTIONS
5,409
0.0035%
$11.03$59,661-0.45%
2024-04-02SaleCertara, Inc.
CERT
PRESIDENT, DRUG DEV SOLUTIONS
14,427
0.009%
$16.85$243,161-22.89%
2024-02-20SaleCertara, Inc.
CERT
PRESIDENT, DRUG DEV SOLUTIONS
5,000
0.0032%
$18.00$90,000-12.46%
2023-06-05SaleCertara, Inc.
CERT
PRESIDENT, INTEGRATED DRUG DEV
19,104
0.0122%
$21.55$411,691-21.9%
2022-11-09SaleCertara, Inc.
CERT
PRESIDENT, INTEGRATED DRUG DEV
2,387
0.0015%
$13.48$32,177+28.94%
2022-08-16SaleCertara, Inc.
CERT
PRESIDENT, INTEGRATED DRUG DEV
10,000
0.0065%
$17.71$177,100+3.55%
2022-06-08SaleCertara, Inc.
CERT
PRESIDENT, INTEGRATED DRUG DEV
10,000
0.0064%
$19.16$191,600-2.46%
2022-04-01SaleCertara, Inc.
CERT
PRESIDENT, INTEGRATED DRUG DEV
3,352
0.0021%
$22.29$74,716-17.24%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.